An Oculocerebrovasculometric Analysis of the Improvement in Arterial Stenosis Following EDTA Chelation Therapy

E.W. McDonagh, DO, FACGP; C.J. Rudolph, DO, PhD; and E. Cheraskin, MD, DMD

Dr. E.W. McDonagh, a member of the Board of Directors of the American Academy of Medical Preventics, founded the McDonagh Medical Center in Gladstone, Missouri, where he practices with Dr. C.J. Rudolph.
Dr. E. Cheraskin is Professor Emeritus and former Chairman of the Department of Oral Medicine at the University of Alabama.

ABSTRACT: Fifty-seven patients were evaluated objectively for cerebral vascular arterial occlusion before and after an average of 28 intravenous infusions of disodium ethylene diamine tetraacetic acid (EDTA). Measurements of arterial occlusion were made with the relatively simple, noninvasive oculocerebrovasculometric analysis. Cerebrovascular arterial occlusion diminished by an average of 18% (from a mean of 28% to a mean of 10%) following therapy (P<0.001). Eighty-eight percent of patients treated with EDTA chelation therapy showed objective improvements in measured cerebrovascular blood flow.

Figure 1

Effect of EDTA and multivitamin-trace mineral therapy on total (right and left) percentage stenosis of carotid and intracranial arteries

Journal of Advancement in Medicine, Volume 2, Numbers 1/2, Spring/Summer 1989.
For the full-text study, go to your nearest medical library or order
The Textbook of EDTA Chelation Therapy.

BACK TO CHELATION RESEARCH

BACK TO MAIN CHELATION PAGE

Mount Rainier Clinic
503 First Street South, Suite 1
Yelm, Washington 98597, USA

Telephone: (360) 458-1061
FAX: (360) 458-1661

email: Click here to send us an email message

Copyright © 2007 John A. Cranton, ARNP, all rights reserved

Last modified:                                           Disclaimer